WANG Ya-kun, ZHAO Yu-ming, CHEN Hong-duo, GUO Ying-jun. A Comparative Study of Anticardiolipin Antibodies in Syphilis and SLE[J].Chinese Journal of Dermatology, 2003, 36(9): 499-500.
[1] Lopez-Soto A, Cervera R, Font J, et al. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid,phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients. Clin Exp Rheumatol, 1997, 15:143-149. [2] Ninomiya C, Taniguchi O, Kato T, et al. Distribution and clinical significance of lupus anticoagulant and anticardiolipin antibody in 349 patients with systemic lupus erythematosus. Intern Med, 1992,31:194-199. [3] Sachse C, Luthke K, Hartung K, et al. Significance of antibodies to cardiolipin in unselected patients with systemic lupus erythematosus: clinical and laboratory associations. The SLE Study Group.Rheumatol Int, 1995, 15:23-29. [4] 尹国华,唱文娟,张开明.皮肤血管炎抗心磷脂抗体含量测定中华皮肤科杂志,1997,30:38-39 [5] Loizou S, Cofiner C, Weetman AP, et al. Immunoglobuliu class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders. Clin Exp Immunol, 1992, 90:434-439.